Evidence map›Paper›PMID 34762835›Full record

ArticleThe lancet. Diabetes & endocrinology2022

Opportunities and challenges in closed-loop systems in type 1 diabetes.

Leah M Wilson, Peter G Jacobs, Michael C Riddell, Dessi P Zaharieva, Jessica R Castle

Abstract read
In one paragraph

Article in The lancet. Diabetes & endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. [Research progress on automated insulin delivery system in the field of diabetes management].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2024
    Review
  8. Observational
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Leah M WilsonDivision of Endocrinology, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, OR 97239, USA. Electronic address: wilsolea@ohsu.edu.
Peter G JacobsArtificial Intelligence for Medical Systems Lab, Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA.
Michael C RiddellMuscle Health Research Centre, School of Kinesiology and Health Science, York University, Toronto, ON, Canada.
Dessi P ZaharievaDepartment of Pediatrics, Stanford University, Stanford, CA, USA.
Jessica R CastleDivision of Endocrinology, Harold Schnitzer Diabetes Health Center, Oregon Health & Science University, Portland, OR 97239, USA.

Funding

Improving glucose control with advanced technology designed for high risk patients with type 1 diabetesR01DK120367 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI JACOBS, PETER G, WILSON, LEAH MEGAN · 2018 to 2021
$2.4M
NIDDK NIH HHS R01 DK120367
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 1Insulin Infusion SystemsHumans

Identifiers

PMID34762835
PMCPMC9255645

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.